Signal transducer and activator of transcription 3 and 5 regulate system Xc- and redox balance in human breast cancer cells

详细信息    查看全文

• 作者：Katja Linher-Melville ; Sina Haftchenary…
• 关键词：System Xc ; xCT ; SLC7A11 ; STAT3 ; STAT5 ; Oxidative stress
• 刊名：Molecular and Cellular Biochemistry
• 出版年：2015
• 出版时间：July 2015
• 年：2015
• 卷：405
• 期：1-2
• 页码：205-221
• 全文大小：916 KB
• 参考文献：1.Lewerenz J, Hewett SJ, Huang Y, Lambros M, Gout PW, Kalivas PW, Massie A, Smolders I, Methner A, Pergande M, Smith SB, Ganapathy V, Maher P (2013) The cystine/glutamate antiporter system x(c)(-) in health and disease: from molecular mechanisms to novel therapeutic opportunities. Antioxid Redox Signal 18:522-55. doi:10.-089/?ars.-011.-391 View Article PubMed Central PubMed
  2.Ishimoto T, Nagano O, Yae T, Tamada M, Motohara T, Oshima H, Oshima M, Ikeda T, Asaba R, Yagi H, Masuko T, Shimizu T, Ishikawa T, Kai K, Takahashi E, Imamura Y, Baba Y, Ohmura M, Suematsu M, Baba H, Saya H (2011) CD44 variant regulates redox status in cancer cells by stabilizing the xCT subunit of system xc(-) and thereby promotes tumor growth. Cancer Cell 19:387-00. doi:10.-016/?j.?ccr.-011.-1.-38 View Article PubMed
  3.Sato H, Shiiya A, Kimata M, Maebara K, Tamba M, Sakakura Y, Makino N, Sugiyama F, Yagami K, Moriguchi T, Takahashi S, Bannai S (2005) Redox imbalance in cystine/glutamate transporter-deficient mice. J Biol Chem 280:37423-7429. doi:10.-074/?jbc.?M506439200 View Article PubMed
  4.Lo M, Wang YZ, Gout PW (2008) The x(c)- cystine/glutamate antiporter: a potential target for therapy of cancer and other diseases. J Cell Physiol 215:593-02. doi:10.-002/?jcp.-1366 View Article PubMed
  5.Chen RS, Song YM, Zhou ZY, Tong T, Li Y, Fu M, Guo XL, Dong LJ, He X, Qiao HX, Zhan QM, Li W (2009) Disruption of xCT inhibits cancer cell metastasis via the caveolin-1/beta-catenin pathway. Oncogene 28:599-09. doi:10.-038/?onc.-008.-14 View Article PubMed
  6.Huang Y, Dai Z, Barbacioru C, Sadee W (2005) Cystine-glutamate transporter SLC7A11 in cancer chemosensitivity and chemoresistance. Cancer Res 65:7446-454. doi:10.-158/-008-5472.?CAN-04-4267 View Article PubMed
  7.Pham AN, Blower PE, Alvarado O, Ravula R, Gout PW, Huang Y (2010) Pharmacogenomic approach reveals a role for the x(c)- cystine/glutamate antiporter in growth and celastrol resistance of glioma cell lines. J Pharmacol Exp Ther 332:949-58. doi:10.-124/?jpet.-09.-62248 View Article PubMed
  8.Verrey F, Closs EI, Wagner CA, Palacin M, Endou H, Kanai Y (2004) CATs and HATs: the SLC7 family of amino acid transporters. Pflugers Arch 447:532-42. doi:10.-007/?s00424-003-1086-z View Article PubMed
  9.Bannai S (1984) Induction of cystine and glutamate transport activity in human fibroblasts by diethyl maleate and other electrophilic agents. J Biol Chem 259:2435-440PubMed
  10.Sato H, Nomura S, Maebara K, Sato K, Tamba M, Bannai S (2004) Transcriptional control of cystine/glutamate transporter gene by amino acid deprivation. Biochem Biophys Res Commun 325:109-16. doi:10.-016/?j.?bbrc.-004.-0.-09 View Article PubMed
  11.Bannai S, Sato H, Ishii T, Sugita Y (1989) Induction of cystine transport activity in human fibroblasts by oxygen. J Biol Chem 264:18480-8484PubMed
  12.Sato H, Fujiwara K, Sagara J, Bannai S (1995) Induction of cystine transport activity in mouse peritoneal macrophages by bacterial lipopolysaccharide. Biochem J 310(Pt 2):547-51PubMed Central PubMed
  13.Jackman NA, Uliasz TF, Hewett JA, Hewett SJ (2010) Regulation of system x(c)(-)activity and expression in astrocytes by interleukin-1 beta: implications for hypoxic neuronal injury. Glia 58:1806-815. doi:10.-002/?glia.-1050 View Article PubMed
  14.Sims B, Clarke M, Njah W, Hopkins ES, Sontheimer H (2010) Erythropoietin-induced neuroprotection requires cystine glutamate exchanger activity. Brain Res 1321:88-5. doi:10.-016/?j.?brainres.-010.-1.-40 View Article PubMed Central PubMed
  15.Liu X, Resch J, Rush T, Lobner D (2012) Functional upregulation of system xc- by fibroblast growth factor-2. Neuropharmacology 62:901-06. doi:10.-016/?j.?neuropharm.-011.-9.-19 View Article PubMed
  16.Yang Y, Yee D (2014) IGF-I regulates redox status in breast cancer cells by activating the amino acid transport molecule xC. Cancer Res 74:2295-305. doi:10.-158/-008-5472.?CAN-13-1803 View Article PubMed Central PubMed
  17.Lall MM, Ferrell J, Nagar S, Fleisher LN, McGahan MC (2008) Iron regulates L-cystine uptake and glutathione levels in lens epithelial and retinal pigment epithelial cells by its effect on cytosolic aconitase. Invest Ophthalmol Vis Sci 49:310-19. doi:10.-167/?iovs.-7-1041 View Article PubMed
  18.Du J, Li XH, Zhang W, Yang YM, Wu YH, Li WQ, Peng J, Li YJ (2014) Involvement of glutamate-cystine/glutamate transporter system in aspirin-induced acute gastric mucosa injury. Biochem Biophys Res Commun 450:135-41. doi:10.-016/?j.?bbrc.-014.-5.-69 View Article PubMed
  19.Lin X, Yang H, Zhang H, Zhou L, Guo Z (2013) A novel transcription mechanism activated by ethanol: induction of Slc7a11 gene expression via inhibition of the DNA-binding activity of transcriptional repressor octamer-binding transcription factor 1 (OCT-1). J Biol Chem 288:14815-4823. doi:10.-074/?jbc.?M113.-66565 View Article PubMed Central PubMed
  20.Liu XX, Li
• 作者单位：Katja Linher-Melville (1)
  Sina Haftchenary (2)
  Patrick Gunning (2)
  Gurmit Singh (1)
  
  1. Department of Pathology and Molecular Medicine, McMaster University, Hamilton, ON, L8S 4L8, Canada
  2. Department of Chemical and Physical Sciences, University of Toronto at Mississauga, Mississauga, ON, L5L 1C6, Canada
  
• 刊物类别：Biomedical and Life Sciences
• 刊物主题：Life Sciences
  Biochemistry
  Medical Biochemistry
  Oncology
  Cardiology
  
• 出版者：Springer Netherlands
• ISSN：1573-4919

文摘

System Xc- is a cystine/glutamate antiporter that contributes to the maintenance of cellular redox balance. The human xCT (SLC7A11) gene encodes the functional subunit of system Xc-. Transcription factors regulating antioxidant defense mechanisms including system Xc- are of therapeutic interest, especially given that aggressive breast cancer cells exhibit increased system Xc- function. This investigation provides evidence that xCT expression is regulated by STAT3 and/or STAT5A, functionally affecting the antiporter in human breast cancer cells. Computationally analyzing two kilobase pairs of the xCT promoter/5-flanking region identified a distal gamma-activated site (GAS) motif, with truncations significantly increasing luciferase reporter activity. Similar transcriptional increases were obtained after treating cells transiently transfected with the full-length xCT promoter construct with STAT3/5 pharmacological inhibitors. Knock-down of STAT3 or STAT5A with siRNAs produced similar results. However, GAS site mutation significantly reduced xCT transcriptional activity, suggesting that STATs may interact with other transcription factors at more proximal promoter sites. STAT3 and STAT5A were bound to the xCT promoter in MDA-MB-231 cells, and binding was disrupted by pre-treatment with STAT inhibitors. Pharmacologically suppressing STAT3/5 activation significantly increased xCT mRNA and protein levels, as well as cystine uptake, glutamate release, and total levels of intracellular glutathione. Our data suggest that STAT proteins negatively regulate basal xCT expression. Blocking STAT3/5-mediated signaling induces an adaptive, compensatory mechanism to protect breast cancer cells from stress, including reactive oxygen species, by up-regulating xCT expression and the function of system Xc-. We propose that targeting system Xc- together with STAT3/5 inhibitors may heighten therapeutic anti-cancer effects.